← Leaderboards
Judy L Meinkoth
University Of Pennsylvania
$6,522,342
Attributed
$6,522,342
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $575.2K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,522,342 · 5
By mechanism
R01$6,310,122 · 4
K02$212,220 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Richard Assoian$21,573,073
- Gregory H. Enders$4,134,887
Others in their field
Top investigators on “Thyroid Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- James A Fagin · Sloan-Kettering Inst Can Research$19,824,240
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Stanley R Hamilton · Johns Hopkins University$17,360,724
- Larry Arthur$15,377,757
- Ignacio I. Wistuba · Ut Southwestern Medical Center$15,303,923
Research focus
Thyroid NeoplasmGuanine Nucleotide Binding ProteinCell ProliferationThyroid GlandThyrotropinGene ExpressionHormone Regulation /Control MechanismGuanosinetriphosphatase Activating ProteinPhosphatidylinositol 3 KinaseEpitheliumBiological Signal TransductionGuanine Nucleotide Exchange FactorsCyclic AmpMitogensApoptosisCell Growth RegulationTissue /Cell CultureMolecularEnzyme InhibitorsProtein Kinase ACellsCell TransformationCell LineRattus
Grant awards (28)
Rap1Gap and Tumor Progression$302,718
R01 · FY2013 · CA · contact PI
Rap1Gap and Tumor Progression$322,040
R01 · FY2012 · CA · contact PI
Rap1Gap and Tumor Progression$322,040
R01 · FY2011 · CA · contact PI
Rap1Gap and Tumor Progression$331,827
R01 · FY2010 · CA · contact PI
Rap1Gap and Tumor Progression$329,925
R01 · FY2009 · CA · contact PI
Isozyme specific effects of PKCs in thyroid cells$231,880
R01 · FY2009 · CA · contact PI
Isozyme specific effects of PKCs in thyroid cells$231,880
R01 · FY2008 · CA · contact PI
RAS and Thyroid Cell Survival$294,391
R01 · FY2007 · DK · contact PI
Isozyme specific effects of PKCs in thyroid cells$231,880
R01 · FY2007 · CA · contact PI
RAS and Thyroid Cell Survival$303,369
R01 · FY2006 · DK · contact PI
Isozyme specific effects of PKCs in thyroid cells$238,805
R01 · FY2006 · CA · contact PI
RAS and Thyroid Cell Survival$310,854
R01 · FY2005 · DK
Isozyme specific effects of PKCs in thyroid cells$264,302
R01 · FY2005 · CA
RAS and Thyroid Cell Survival$337,628
R01 · FY2004 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$287,750
R01 · FY2004 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$52,721
R01 · FY2004 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$279,368
R01 · FY2003 · DK
SIGNALING CROSSTALK AND THYROID CELL SURVIVAL$238,543
R01 · FY2003 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$51,185
R01 · FY2003 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$254,911
R01 · FY2002 · DK
SIGNALING CROSSTALK AND THYROID CELL SURVIVAL$238,543
R01 · FY2002 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$16,572
R01 · FY2002 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$215,794
R01 · FY2001 · DK
SIGNALING CROSSTALK AND THYROID CELL SURVIVAL$204,465
R01 · FY2001 · DK
CROSSTALK BETWEEN CAMP AND RAS IN ENDOCRINE CELLS$106,110
K02 · FY2001 · DK
CROSSTALK BETWEEN CAMP AND RAS IN TSH GROWTH SIGNALING$215,031
R01 · FY2000 · DK
SIGNALING CROSSTALK AND THYROID CELL SURVIVAL$201,700
R01 · FY2000 · DK
CROSSTALK BETWEEN CAMP AND RAS IN ENDOCRINE CELLS$106,110
K02 · FY2000 · DK